Literature DB >> 15990964

Prognostic value of thymidine phosphorylase activity in liver tissue adjacent to hepatocellular carcinoma.

Takahiro Ezaki1, Toru Ikegami, Takashi Maeda, Tomomi Yamada, Teruyoshi Ishida, Makoto Hashizume, Yoshihiko Maehara.   

Abstract

BACKGROUND: Measurement of thymidine phosphorylase (TP) activity in normal liver tissue adjacent to hepatocellular carcinoma (HCC) may predict multicentric recurrence a long time after an operation. The authors investigated this activity in 92 patients with HCC who had a single HCC equal to or less than 5 cm.
METHODS: Fresh samples (tumors with adjacent normal tissues) were collected from 92 patients with HCC who underwent curative hepatic resection. The levels of TP activity in nonfixed, fresh, and frozen HCC specimens with adjacent noncancerous liver tissue were biochemically measured by using an enzyme-linked immunosorbent assay method.
RESULTS: Patients who had a high TP level in normal liver tissue had significantly earlier recurrence (median disease-free survival, 819 days; 95% confidence interval [95% CI], 478-1044 days) compared with patients who had a low TP level (median disease-free survival, 1376 days; lower limit of 95% CI, 921 days; P = 0.0171). Multivariate analysis showed that patients who had a low TP level in adjacent liver tissue had a 0.387-fold higher risk of postoperative recurrence compared with patients who had a high TP level (P = 0.0067).
CONCLUSION: TP activity in normal liver tissue adjacent to HCC is related to tumor occurrence and may predict postoperative tumor recurrence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15990964     DOI: 10.1007/s10147-005-0488-7

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  27 in total

Review 1.  Natural history of hepatitis C: its impact on clinical management.

Authors:  A M Di Bisceglie
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

2.  Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor.

Authors:  F Ishikawa; K Miyazono; U Hellman; H Drexler; C Wernstedt; K Hagiwara; K Usuki; F Takaku; W Risau; C H Heldin
Journal:  Nature       Date:  1989-04-13       Impact factor: 49.962

3.  Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

Authors:  K Ikeda; S Saitoh; Y Arase; K Chayama; Y Suzuki; M Kobayashi; A Tsubota; I Nakamura; N Murashima; H Kumada; M Kawanishi
Journal:  Hepatology       Date:  1999-04       Impact factor: 17.425

4.  Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases.

Authors:  K Yuki; S Hirohashi; M Sakamoto; T Kanai; Y Shimosato
Journal:  Cancer       Date:  1990-11-15       Impact factor: 6.860

5.  Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis.

Authors:  J Belghiti; Y Panis; O Farges; J P Benhamou; F Fekete
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

6.  Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC.

Authors:  K Tarao; S Takemiya; S Tamai; Y Sugimasa; S Ohkawa; M Akaike; H Tanabe; A Shimizu; M Yoshida; A Kakita
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

7.  Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues.

Authors:  M Nishida; A Hino; K Mori; T Matsumoto; T Yoshikubo; H Ishitsuka
Journal:  Biol Pharm Bull       Date:  1996-11       Impact factor: 2.233

8.  Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma.

Authors:  E Adachi; T Maeda; T Matsumata; K Shirabe; N Kinukawa; K Sugimachi; M Tsuneyoshi
Journal:  Gastroenterology       Date:  1995-03       Impact factor: 22.682

9.  Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma.

Authors:  K Ikeda; S Saitoh; A Tsubota; Y Arase; K Chayama; H Kumada; G Watanabe; M Tsurumaru
Journal:  Cancer       Date:  1993-01-01       Impact factor: 6.860

10.  Analysis of proliferating hepatocytes using a monoclonal antibody against proliferating cell nuclear antigen/cyclin in embedded tissues from various liver diseases fixed in formaldehyde.

Authors:  N Kawakita; S Seki; H Sakaguchi; A Yanai; T Kuroki; Y Mizoguchi; K Kobayashi; T Monna
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

View more
  3 in total

1.  Prognostic value of purinergic P2X7 receptor expression in patients with hepatocellular carcinoma after curative resection.

Authors:  Haiou Liu; Weisi Liu; Zheng Liu; Yidong Liu; Weijuan Zhang; Le Xu; Jiejie Xu
Journal:  Tumour Biol       Date:  2015-02-27

2.  Discovering hidden connections among diseases, genes and drugs based on microarray expression profiles with negative-term filtering.

Authors:  Jain-Shing Wu; E-Fong Kao; Chung-Nan Lee
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

3.  Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma.

Authors:  Hiroshi Kono; Hideki Fujii; Shinji Furuya; Michio Hara; Kazuyoshi Hirayama; Yoshihiro Akazawa; Yuuki Nakata; Masato Tsuchiya; Naohiro Hosomura; Chao Sun
Journal:  World J Gastroenterol       Date:  2016-10-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.